Closed pnrobinson closed 1 year ago
@MickeySegal
I do not think the "X drug toxicity" items are good HPO terms because they can include multiple phenotypic features and also include etiology. Possibly terms from the OAE are better suited, e.g., : https://www.ebi.ac.uk/ols4/ontologies/oae/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FOAE_0005827
thoughts?
"Cholinergic syndrome" would be fine, but as someone who did a PhD thesis on cholinergic receptors, it doesn't seem much different.
I mean the issue is that if we start to introduce terms such as X toxicity for side effects caused by medication X, we will need to add terms for all medications and this is probably not the way to go?
It is meant to be the finding for the diagnosis "Anticholinergic intoxication".
In the HPO universe, these "intoxication" items would probably be best described as (acute) diseases -- they have a specific etiology, they have a collection of phenotypic features (here: delirium, restlessness and picking at imaginary objects), a typical clinical course and a treatment. So these would be good Mondo terms. @nicolevasilevsky I am closing the HPO NTRs, and we can think about whether to add a "toxidrome" branch to Mondo.
New term request Anticholinergic drug toxicity (segal_211028185209): Atropine, benztropine, scopolamine, diphenhydramine, antihistamines, jimson weed, nightshade, phenothiazines, tricyclics UMLS: 0416669